Results 161 to 170 of about 13,452 (195)

Theranostic Capacity of a Mucin 16-targeted Antibody for Ovarian Cancer. [PDF]

Radiol Imaging Cancer
Tan KV.
europepmc   +1 more source

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with ¹³¹I-omburtamab for leptomeningeal disease. [PDF]

EJNMMI Res
Prasad K, Serencsits BE, Chu BP, Dauer LT, Donzelli M, Basu E, Kramer K, Pandit-Taskar N.   +7 more
europepmc   +1 more source

Therapeutic efficacy of ¹⁷⁷Lu‐CHX‐A″‐DTPA‐hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

, 2008
Marcus P. Kelly, Sze Ting Lee, Fook Lee, Fiona E. Smyth, Ian D. Davis, Martin W. Brechbiel, Andrew M. Scott   +6 more
openalex   +1 more source

Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review. [PDF]

Front Oncol
Sanwick AM, Chaple IF.
europepmc   +1 more source

Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab. [PDF]

Chem Sci
Rudd SE, Van Zuylekom J, Cullinane C, Blyth BJ, Donnelly PS.   +4 more
europepmc   +1 more source

Engineered Antibodies as Cancer Radiotheranostics. [PDF]

Adv Sci (Weinh)
Wei Z, Li B, Wen X, Jakobsson V, Liu P, Chen X, Zhang J.   +6 more
europepmc   +1 more source

Carbon ion irradiation mobilizes antitumor immunity: from concept to the clinic. [PDF]

Radiat Oncol
Liu S, He X, Liang S, Wu A, Liu L, Hu W.
europepmc   +1 more source

Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions. [PDF]

Pharmaceuticals (Basel)
Calistri S, Ottaviano G, Ubaldini A.
europepmc   +1 more source

Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer. [PDF]

J Transl Med
Qiu J, Xia Y, Bao Y, Cheng J, Liu L, Qian D.   +5 more
europepmc   +1 more source

Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [²¹¹At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care. [PDF]

Cancers (Basel)
Rousseau C, Baumgartner P, Heymann MF, Taupin M, Geffroy M, Chatal JF, Gautier G, Allam N, Gaschet J, Eychenne R, Guérard F, Gestin JF, Varmenot N, Chérel M.   +13 more
europepmc   +1 more source